Movatterモバイル変換


[0]ホーム

URL:


Jump to content
WikipediaThe Free Encyclopedia
Search

Interleukin 37

From Wikipedia, the free encyclopedia
(Redirected fromIL1F7)

Protein-coding gene in the species Homo sapiens
"IL-37" redirects here. For the road, seeIllinois Route 37.
IL37
Identifiers
AliasesIL37, FIL1, FIL1(ZETA), FIL1Z, IL-1F7, IL-1H, IL-1H4, IL-1RP1, IL-37, IL1F7, IL1H4, IL1RP1, interleukin 37, IL-23
External IDsOMIM:605510;HomoloGene:105713;GeneCards:IL37;OMA:IL37 - orthologs
Gene location (Human)
Chromosome 2 (human)
Chr.Chromosome 2 (human)[1]
Chromosome 2 (human)
Genomic location for IL37
Genomic location for IL37
Band2q14.1Start112,911,165bp[1]
End112,918,882bp[1]
RNA expression pattern
Bgee
HumanMouse (ortholog)
Top expressed in
  • skin of arm

  • skin of leg

  • skin of thigh

  • nipple

  • skin of abdomen

  • vena cava

  • skin of hip

  • subthalamic nucleus

  • body of tongue

  • ventral tegmental area
    n/a
More reference expression data
BioGPS
More reference expression data
Gene ontology
Molecular function
Cellular component
Biological process
Sources:Amigo /QuickGO
Orthologs
SpeciesHumanMouse
Entrez

27178

n/a

Ensembl

ENSG00000125571

n/a

UniProt

Q9NZH6

n/a

RefSeq (mRNA)

NM_014439
NM_173202
NM_173203
NM_173204
NM_173205

n/a

RefSeq (protein)

NP_055254
NP_775294
NP_775295
NP_775296
NP_775297

n/a

Location (UCSC)Chr 2: 112.91 – 112.92 Mbn/a
PubMed search[2]n/a
Wikidata
View/Edit Human

Interleukin 37 (IL-37), also known asInterleukin-1 family member 7 (IL-1F7), is ananti-inflammatorycytokine important for the downregulation ofpro-inflammatory cytokine production as well as the suppression oftumor cell growth.[3]

Gene location and structure

[edit]

TheIL-37gene is in the human located on thelong chromosome arm ofchromosome 2. There has not been found anyhomolog gene in micegenome.[4] IL-37 undergoesalternative splicing with 5 different splice variants depending on which of the 6 possibleexons are being expressed: IL-37a-e.[5] IL-37b is the largest and most studied one; it shares thebeta barrel structure that is spread within theinterleukin-1 family.[3]

Gene expression

[edit]

IL-37a,b,c are beingexpressed in a variety oftissues -thymus,lung,colon,uterus,bone marrow. It is produced byimmune cells, most of which are relevant to theimmune inflammation response. Examples includenatural killer cells, activatedB lymphocytes,circulating blood monocytes, tissuemacrophages,keratinocytes orepithelial cells.

Some IL-37isoforms aretissue specific and have varying lengths depending on which exons are being expressed:

IL-37a is found in thebrain. The isoform includes exons 3, 4, 5, and 6 and the isoform is 192amino acids in length

IL-37b is found in thekidney,bone marrow,blood,skin,respiratory andurogenital tract. Exons 1, 2, 4, 5, and 6 are expressed and the isoform is 218 amino acids in length.

IL-37c is found in theheart, and contains exons 1, 2, 5, and 6 for a total amino acid length of 197.

IL-37d is found in thebone marrow and includes exons 1, 4, 5, and 6 for a total length of 197.

IL-37e is found in thetestis and includes exons 1, 5, and 6 totaling 157 amino acids.[3][6]

Function

[edit]

The mechanism of IL-37 functions is still to be elucidated. Known functions of IL-37 includeanti-inflammatory effects, tumor suppression, and antimicrobial responses. IL-37 actsintracellulary andextracellulary, classifying the cytokine as dual-function.[3]

IL-37 synthesis

[edit]

IL-37, similar to other members of theinterleukin-1 family, is synthesized by blood monocytes in a precursor form and secreted into the cytoplasm in response to inflammatory signaling. Examples of relevant inflammatory signals include TLR agonists, IL-1β, or TGF-β.[5] Full maturation requires cleavage byCaspase-1.[7]

Immune system inhibition

[edit]

IL-37 is known to have immunosuppression properties through two different binding mechanisms:

Interaction with IL-18 cell surface receptors - Intracellular IL-37 can be released from cells followingnecrosis orapoptosis.[6] IL-37 has two similaramino acid residues withIL-18, and thus extracellular IL-37 can interact withIL-18 receptor (IL-18R) and co-receptor IL-1 receptor 8 (IL-1R8). The affinity of IL-37b to IL-18R alpha subunit is much lower compared to IL-18. IL-37b interacts withIL-18 binding protein (IL-18BP), that is an antagonist of IL-18. The binding of IL-37b enhances the IL-18BP functions and can upregulate anti-inflammatory signals.[4][7]

Binding to SMAD3 receptor - Mature intracellular IL-37 can form functional complexes withphosphorylated or unphosphorylatedSmad3,which can be transported to thecell nucleus. Nucleus IL-37 can have a direct inhibition function on theexpression ofpro-inflammatory cytokine gene transcription. Affected cytokines includeIL-1β,IFN-γ,IL-6, andTNF-α.[5][8][6]

Tumor-controlled expression

[edit]

IL-37 functions are active at low IL-37 concentrations. Higher concentrations leads to inactivation via dimer formation.[6] Experiments also show that certain cancer strains correspond to changes in IL-37 expression levels.Breast cancer andovarian cancer are associated with elevated expression of IL-37.Colon cancer,lung cancer,Multiple Myeloma, andHepatoma Carcinoma were correlated with decreased expression of IL-37 expression in affected areas.[5]

See also

[edit]

References

[edit]
  1. ^abcGRCh38: Ensembl release 89: ENSG00000125571Ensembl, May 2017
  2. ^"Human PubMed Reference:".National Center for Biotechnology Information, U.S. National Library of Medicine.
  3. ^abcdWang L, Quan Y, Yue Y, Heng X, Che F (April 2018)."Interleukin-37: A crucial cytokine with multiple roles in disease and potentially clinical therapy".Oncology Letters.15 (4):4711–4719.doi:10.3892/ol.2018.7982.PMC 5840652.PMID 29552110.
  4. ^abNold MF, Nold-Petry CA, Zepp JA, Palmer BE, Bufler P, Dinarello CA (November 2010)."IL-37 is a fundamental inhibitor of innate immunity".Nature Immunology.11 (11):1014–1022.doi:10.1038/ni.1944.PMC 3537119.PMID 20935647.
  5. ^abcdMei Y, Liu H (April 2019)."IL-37: An anti-inflammatory cytokine with antitumor functions".Cancer Reports.2 (2) e1151.doi:10.1002/cnr2.1151.PMC 7941439.PMID 32935478.
  6. ^abcdBello RO, Chin VK, Abd Rachman Isnadi MF, Abd Majid R, Atmadini Abdullah M, Lee TY, et al. (April 2018)."The Role, Involvement and Function(s) of Interleukin-35 and Interleukin-37 in Disease Pathogenesis".International Journal of Molecular Sciences.19 (4): 1149.doi:10.3390/ijms19041149.PMC 5979316.PMID 29641433.
  7. ^abPan Y, Wen X, Hao D, Wang Y, Wang L, He G, Jiang X (February 2020)."The role of IL-37 in skin and connective tissue diseases".Biomedicine & Pharmacotherapy.122 109705.doi:10.1016/j.biopha.2019.109705.PMID 31918276.
  8. ^Jia H, Liu J, Han B (2018-04-01)."Reviews of Interleukin-37: Functions, Receptors, and Roles in Diseases".BioMed Research International.2018 3058640.doi:10.1155/2018/3058640.PMC 5899839.PMID 29805973.

Further reading

[edit]

External links

[edit]
By family
Chemokine
CCL
CXCL
CX3CL
XCL
TNF
Interleukin
Type I
(grouped by
receptor
subunit)
γ chain
β chain
IL6 like/gp130
IL12 family/IL12RB1
Other
Type II
IL10 family
Interferon
I
II
Ig superfamily
IL17 family
Other
By function/
cell
Chemokine
CSF
Erythropoietin
G-CSF (CSF3)
GM-CSF (CSF2)
M-CSF (CSF1)
SCF (c-Kit)
Thrombopoietin
Interferon
IFNAR (α/β, I)
IFNGR (γ, II)
IFNLR (λ, III)
  • See IL-28R (IFNLR)here instead.
Interleukin
TGFβ
TNF
Others
JAK
(inhibitors)
JAK1
JAK2
JAK3
TYK2
Others
Retrieved from "https://en.wikipedia.org/w/index.php?title=Interleukin_37&oldid=1313914320"
Category:
Hidden categories:

[8]ページ先頭

©2009-2025 Movatter.jp